Corporate
News Releases
2022
December
November
Nutraceuticals
New skin care brandIntroducing Sakuraé Double Action Serum - Japan's first "double brightening" effect -
Nutraceuticals
1기리쉬를 xbet Pharmaceutical Finalizes Business Collaboration Agreement for Horizontal Recycling of PET Bottles
Nutraceuticals
Favorable Decision of the Supreme Court on Lawsuit on Patent Right Held in Relation to 1기리쉬를 xbet Pharmaceutical Foods Containing Equol
1기리쉬를 xbets
1기리쉬를 xbet Announces the Launch in Japan of Auto-Injector Dosage Form for AJOVY®Subcutaneous Injection 225mg 1기리쉬를 xbet Preventive Treatment of Migraine
1기리쉬를 xbets
Announcement of Termination of Co-Development and Exclusive MarketingAgreements with Takara Bio 1기리쉬를 xbet NY-ESO-1・siTCR®gene therapy candidate
Corporate
1기리쉬를 xbet Opens Osaka Research Center for Drug Discovery in Osaka Prefecture, Japan
October
1기리쉬를 xbets
Avanir Pharmaceuticals, Inc. Business Will Be IntegratedInto 1기리쉬를 xbet America Pharmaceuticals, Inc. as of January 1, 2023
Nutraceuticals
1기리쉬를 xbet Pharmaceutical Supports Tokyo Legacy Half Marathon 2022Helping runners to complete the distance and set new records
1기리쉬를 xbets
1기리쉬를 xbet and Jolly Good to Launch FACEDUO, a Virtual Reality Support Program forPatients with Schizophrenia and Their Supporters
Nutraceuticals
Announcement of Price Revisions 1기리쉬를 xbet Applicable Products
September
1기리쉬를 xbets
1기리쉬를 xbet to Launch QuickNaviTM-Noro3, a Norovirus Antigen Quick Detection Kit - Minimum detection sensitivity improved compared to QuickNaviTM-Noro2 -
Nutraceuticals
Launch of 1기리쉬를 xbet BLUE PLANET in IndonesiaSustainability Program Aims to Contribute to Local Environmental Efforts
1기리쉬를 xbets
1기리쉬를 xbet announces EC approval of Lupkynis® (voclosporin) as first oral treatment for active lupus nephritis
Nutraceuticals
Launch of SOYJOY Sweet PotatoPopular ingredient flavors new whole-soy nutrition bar
1기리쉬를 xbets
1기리쉬를 xbet and Lundbeck Announce U.S. FDA Acceptance of New Drug Application forAripiprazole 2-month, Ready-to-Use, Long-acting Injectable to Treat Schizophrenia andBipolar I Disorder in Adults
1기리쉬를 xbets
1기리쉬를 xbet Pharmaceutical announces positive results of phase III trial in Japan for brexpiprazole in the treatment of major depressive disorder
1기리쉬를 xbets
1기리쉬를 xbet Measurement Kit to be Covered by National Health Insurance in Japan forPhiladelphia-Chromosome-Positive, Acute Lymphoblastic Leukemia
August
Nutraceuticals
1기리쉬를 xbet Subsidiaries Become Official Supporters of ASEAN Football Federation ChampionshipContributing to Safe Tournament Management and Optimum Conditioning for Players and Staf
Nutraceuticals
Announcement of Price Revisions 1기리쉬를 xbet Applicable Products
1기리쉬를 xbets
European Medicines Agency commences review of oral fixed-dosecombination of decitabine and cedazuridine 1기리쉬를 xbet the treatment ofadults with acute myeloid leukemia
1기리쉬를 xbets
PAN-TB Collaboration to Advance Investigational Tuberculosis Drug Regimens to Phase 2 Clinical Trials
Nutraceuticals
Presentation of Research Regarding Compounds Contributing to Alleviation of Premenstrual Symptoms
1기리쉬를 xbets
1기리쉬를 xbet Pharmaceutical and Lundbeck present positive results showing reduced agitation in patients with Alzheimer's dementia treated with brexpiprazole at the 2022 Alzheimer's Association International Conference
July
1기리쉬를 xbets
1기리쉬를 xbet receives positive CHMP opinion for LupkynisTM(voclosporin)1기리쉬를 xbet the treatment of active lupus nephritis
Nutraceuticals
Introducing New B240 TabletsEf1기리쉬를 xbettless way to consume a unique ingredient 1기리쉬를 xbet maintenance of physical condition
Corporate
Full-scale Launch of "Kenkokeiei Tsunagaru Support" Service1기리쉬를 xbet Pharmaceutical Supports Resolution of Health Issues for Small & Medium-sized Enterprises
June
Nutraceuticals
POCARI SWEAT 250ml Returnable Bottle 1기리쉬를 xbet Distribution via Circular Shopping Plat1기리쉬를 xbetm 'Loop'
1기리쉬를 xbets
1기리쉬를 xbet Pharmaceutical and Lundbeck announce positive results showing reduced agitation in patients with Alzheimer's dementia treated with brexpiprazole
1기리쉬를 xbets
European Medicines Agency Commences Review of Aripiprazole2-Month Long-Acting Injectable 1기리쉬를 xbet the Maintenance Treatment of Schizophrenia in Adult Patients Stabilised with Aripiprazole
1기리쉬를 xbets
1기리쉬를 xbet Obtains Approval in Japan for Auto-Injector Dosage Form for AJOVY®Subcutaneous Injection 225 mg 1기리쉬를 xbet Preventive Treatment of Migraine
1기리쉬를 xbets
1기리쉬를 xbet Enters Collaboration with xFOREST Therapeutics on RNA Structure- Targeted Drug Discovery Covering Multiple Diseases
Nutraceuticals
1기리쉬를 xbet Pharmaceutical Publishes Paper Investigating Binding Property of Salivary IgA on Pathogenic Microorganisms
1기리쉬를 xbets
Launch in Japan of Moizerto®Ointment, a Treatment 1기리쉬를 xbet Atopic Dermatitis
May
Nutraceuticals
POCARI SWEAT × TOKUSHIMA VORTIS Football Dream Project1기리쉬를 xbet and Tokushima Vortis collaborate to support overseas promotion of health through sports activities and regional vitalization in Tokushima
1기리쉬를 xbets
Launch in Japan of SAMTASU®1기리쉬를 xbet IV Infusion, a V2-Receptor Antagonist 1기리쉬를 xbet the Treatment of Cardiac Edema
1기리쉬를 xbets
Announcement of Termination of Global License Agreements 1기리쉬를 xbet Renal Anemia Treatment with Akebia Therapeutics, Inc.
Corporate
Four 1기리쉬를 xbet Group Companies in Indonesia Adopts CO2-Free Electricity - Approximately 13% reduction in annual CO2emissions -
April
1기리쉬를 xbets
1기리쉬를 xbet and Ai-BrainScience Announce Sales Collaboration Agreement for New Cognitive Function Testing Application That Uses Eye Tracking Technology
Corporate
1기리쉬를 xbet Group Joins RE100 International Initiative - Committed to 100% Renewable Energy -
1기리쉬를 xbets
Osaka University and 1기리쉬를 xbet Pharmaceutical to Enter into an Exclusive License Agreement on New Anti-tumor Antibody
March
1기리쉬를 xbets
Akebia Therapeutics Receives Complete Response Letter from U.S. FDA1기리쉬를 xbet Vadadustat 1기리쉬를 xbet the Treatment of Anemia associated with Chronic Kidney Diseasein Adult Patients
1기리쉬를 xbets
1기리쉬를 xbet Subsidiary to Receive Payment and Royalties from Approval in U.S. ofRadioligand Therapy for Metastatic Castration-Resistant Prostate Cancer- Out-licensed by ABX in Germany, an indirectly-owned subsidiary of 1기리쉬를 xbet Pharmaceutical -
1기리쉬를 xbets
1기리쉬를 xbet Obtains Approval in Japan for SAMTASU®1기리쉬를 xbet I.V. Infusion, a V2 -Receptor Antagonist 1기리쉬를 xbet the Treatment of Cardiac Edema
Corporate
Packaging 1기리쉬를 xbet a Sustainable FuturePOCARI SWEAT to Introduce Recycled PET 1기리쉬를 xbet Bottles from Spring 2022
Corporate
1기리쉬를 xbet Pharmaceutical Appointments of Board Members and Statutory Auditors(PDF: 58.8 KB)
Nutraceuticals
～1기리쉬를 xbet Pharmaceutical Survey of "Working Women's Health Consciousness"～ Indication that women’s health concerns (PMS, menopause) significantly affect career paths. Need for recognition as "corporate issues" beyond individual efforts.
Nutraceuticals
Introducing New Calorie Mate BLOCK VanillaNutritional Balance in Everyday Life 1기리쉬를 xbet People of All Ages
February
Nutraceuticals
1기리쉬를 xbet Extends Its Deep Expertise in Soy-Based Products to Launch SOYJOY 100% Plant-Based Series
Corporate
Favorable Judgment on Lawsuit on Patent Right Held in Relation to 1기리쉬를 xbet Pharmaceutical Foods Containing Equol
Corporate
1기리쉬를 xbet Pharmaceutical Certified as Sports Yell Company for 5th Consecutive Year- Collaboration among 1기리쉬를 xbet Group Companies to Support Employees' Ongoing Fitness Efforts -
January
1기리쉬를 xbets
1기리쉬를 xbet Enters Agreement with Jolly Good for Co-Development and Sales Rights in Japanfor a Social Skills Training Platform Using Virtual Reality in the Psychiatric Field
Corporate
Favorable judgment on lawsuit 1기리쉬를 xbet revocation of trial decision on patent right held in relation to equol-containing foods
1기리쉬를 xbets